LLY vs RVTY
By Alex · Tickerpine
Eli Lilly and Company vs Revvity, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | LLY | RVTY |
|---|---|---|
| Price | $1,208.12 | $113.02 |
| Market cap | $1.08T | $12.61B |
| P/E ratio | 42.9 | 54.3 |
| ROE | 107.46% | 3.23% |
| Profit margin | 34.99% | 8.26% |
| Revenue growth | 55.50% | 7.00% |
| Dividend yield | 0.57% | 0.25% |
| Beta | 0.52 | 1.11 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
LLY vs RVTY in plain English
- LLY is the bigger company — about 85.4× the market cap of RVTY.
- LLY is cheaper on earnings (P/E 42.9 vs 54.3).
- LLY earns a higher return on equity (107% vs 3%).
- LLY is growing revenue faster (56% vs 7%).
- LLY has the higher dividend yield (0.57% vs 0.25%).
How would $1,000 have done in each?
LLY return calculator
See what $1,000 in Eli Lilly and Company would be worth today.
RVTY return calculator
See what $1,000 in Revvity, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.